Premium
P1‐227: MITOCHONDRIAL MEMBRANE POTENTIAL INFLUENCE ON PROCESSING AND LOCALIZATION OF APP
Author(s) -
Wilkins Heather M.,
Weidling Ian,
Swerdlow Russell H.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.232
Subject(s) - oligomycin , depolarization , membrane potential , mitochondrion , bioenergetics , atp synthase , inner mitochondrial membrane , microbiology and biotechnology , biology , biophysics , biochemistry , chemistry , atpase , enzyme
neuroblastoma cells and cell homogenates, and reversed the Abinduced increases in superoxide formation. KU-32 increased the Vmax of mitochondrial Complex I without affecting levels of Complex I proteins, and blocked the Ab inhibition of Complex I. We determined that the effects on Complex I were the result of inhibition of pyruvate dehydrogenase kinase (PDHK), both in isolated brain mitochondria and in SH-SY5Y cells. PDHK inhibition by the classic enzyme inhibitor, dichloroacetate, led to neuroprotection from Ab-induced cell injury similarly to KU-32. Inhibition of PDHK would lead to activation of the PDH complex, increase acetyl-CoA generation, stimulate the tricarboxylic acid cycle and Complex I, and enhance oxidative phosphorylation. Bioenergetic measurements in SH-SY5Y showed increases in oxygen consumption rates in KU-32-treated cells. Conclusions:These studies point to the potential value of PDHK as a target in AD therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom